Concurrent Chemoradiation Therapy (cCRT): The Standard of Care in Unresectable Stage III NSCLC

Hear Dr Mark Socinski discuss advancements in the treatment of unresectable Stage III non-small cell lung cancer (NSCLC), as well as possible ways to help manage associated toxicities and adverse events associated with concurrent chemoradiation therapy (cCRT).